Rachel L. Nosheny, Melanie Miller, Catherine Conti, Derek Flenniken, Miriam Ashford, Adam Diaz, Juliet Fockler, Diana Truran, Winnie Kwang, Shaveta Kanoria, Dallas Veitch, Robert C. Green, Michael W. Weiner, Alzheimer's Disease Neuroimaging Initiative
{"title":"The ADNI Administrative Core: Ensuring ADNI's success and informing future AD clinical trials","authors":"Rachel L. Nosheny, Melanie Miller, Catherine Conti, Derek Flenniken, Miriam Ashford, Adam Diaz, Juliet Fockler, Diana Truran, Winnie Kwang, Shaveta Kanoria, Dallas Veitch, Robert C. Green, Michael W. Weiner, Alzheimer's Disease Neuroimaging Initiative","doi":"10.1002/alz.14311","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <p>The Alzheimer's Disease Neuroimaging Initiative (ADNI) Administrative Core oversees and coordinates all ADNI activities, to ensure the success and maximize the impact of ADNI in advancing Alzheimer's disease (AD) research and clinical trials. It manages finances and develops policies for data sharing, publications using ADNI data, and access to ADNI biospecimens. The Core develops and executes pilot projects to guide future ADNI activities and identifies key innovative methods for inclusion in ADNI. For ADNI4, the Administrative Core collaborates with the Engagement, Clinical, and Biomarker Cores to develop and evaluate novel, digital methods and infrastructure for participant recruitment, screening, and assessment of participants. The goal of these efforts is to enroll 500 participants, including > 50% from underrepresented populations, 40% with mild cognitive impairment, and 80% with elevated AD biomarkers. This new approach also provides a unique opportunity to validate novel methods.</p>\n </section>\n \n <section>\n \n <h3> Highlights</h3>\n \n <div>\n <ul>\n \n <li>The Alzheimer's Disease Neuroimaging Initiative (ADNI) Administrative Core oversees and coordinates all ADNI activities.</li>\n \n <li>The overall goal is to ensure ADNI's success and help design future Alzheimer's disease (AD) clinical trials.</li>\n \n <li>A key innovation is data sharing without embargo to maximize scientific impact.</li>\n \n <li>For ADNI4, novel, digital methods for recruitment and assessment were developed.</li>\n \n <li>New methods are designed to improve the participation of underrepresented populations.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"20 12","pages":"9004-9013"},"PeriodicalIF":11.1000,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14311","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14311","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The Alzheimer's Disease Neuroimaging Initiative (ADNI) Administrative Core oversees and coordinates all ADNI activities, to ensure the success and maximize the impact of ADNI in advancing Alzheimer's disease (AD) research and clinical trials. It manages finances and develops policies for data sharing, publications using ADNI data, and access to ADNI biospecimens. The Core develops and executes pilot projects to guide future ADNI activities and identifies key innovative methods for inclusion in ADNI. For ADNI4, the Administrative Core collaborates with the Engagement, Clinical, and Biomarker Cores to develop and evaluate novel, digital methods and infrastructure for participant recruitment, screening, and assessment of participants. The goal of these efforts is to enroll 500 participants, including > 50% from underrepresented populations, 40% with mild cognitive impairment, and 80% with elevated AD biomarkers. This new approach also provides a unique opportunity to validate novel methods.
Highlights
The Alzheimer's Disease Neuroimaging Initiative (ADNI) Administrative Core oversees and coordinates all ADNI activities.
The overall goal is to ensure ADNI's success and help design future Alzheimer's disease (AD) clinical trials.
A key innovation is data sharing without embargo to maximize scientific impact.
For ADNI4, novel, digital methods for recruitment and assessment were developed.
New methods are designed to improve the participation of underrepresented populations.
期刊介绍:
Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.